Cargando…

Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host

BACKGROUND: Babesia rossi is a leading cause of morbidity and mortality among the canine population of sub-Saharan Africa, but pathogenesis remains poorly understood. Previous studies of B. rossi infection were derived from clinical cases, in which neither the onset of infection nor the infectious i...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Rachel L., Goddard, Amelia, Boddapati, Arun, Brooks, Steven, Schoeman, Johan P., Lack, Justin, Leisewitz, Andrew, Ackerman, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369750/
https://www.ncbi.nlm.nih.gov/pubmed/34399690
http://dx.doi.org/10.1186/s12864-021-07889-4
_version_ 1783739351416438784
author Smith, Rachel L.
Goddard, Amelia
Boddapati, Arun
Brooks, Steven
Schoeman, Johan P.
Lack, Justin
Leisewitz, Andrew
Ackerman, Hans
author_facet Smith, Rachel L.
Goddard, Amelia
Boddapati, Arun
Brooks, Steven
Schoeman, Johan P.
Lack, Justin
Leisewitz, Andrew
Ackerman, Hans
author_sort Smith, Rachel L.
collection PubMed
description BACKGROUND: Babesia rossi is a leading cause of morbidity and mortality among the canine population of sub-Saharan Africa, but pathogenesis remains poorly understood. Previous studies of B. rossi infection were derived from clinical cases, in which neither the onset of infection nor the infectious inoculum was known. Here, we performed controlled B. rossi inoculations in canines and evaluated disease progression through clinical tests and whole blood transcriptomic profiling. RESULTS: Two subjects were administered a low inoculum (10(4) parasites) while three received a high (10(8) parasites). Subjects were monitored for 8 consecutive days; anti-parasite treatment with diminazene aceturate was administered on day 4. Blood was drawn prior to inoculation as well as every experimental day for assessment of clinical parameters and transcriptomic profiles. The model recapitulated natural disease manifestations including anemia, acidosis, inflammation and behavioral changes. Rate of disease onset and clinical severity were proportional to the inoculum. To analyze the temporal dynamics of the transcriptomic host response, we sequenced mRNA extracted from whole blood drawn on days 0, 1, 3, 4, 6, and 8. Differential gene expression, hierarchical clustering, and pathway enrichment analyses identified genes and pathways involved in response to hemolysis, metabolic changes, and several arms of the immune response including innate immunity, adaptive immunity, and response to viral infection. CONCLUSIONS: This work comprehensively characterizes the clinical and transcriptomic progression of B. rossi infection in canines, thus establishing a large mammalian model of severe hemoprotozoal disease to facilitate the study of host-parasite biology and in which to test novel anti-disease therapeutics. The knowledge gained from the study of B. rossi in canines will not only improve our understanding of this emerging infectious disease threat in domestic dogs, but also provide insight into the pathobiology of human diseases caused by Babesia and Plasmodium species. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07889-4.
format Online
Article
Text
id pubmed-8369750
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83697502021-08-18 Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host Smith, Rachel L. Goddard, Amelia Boddapati, Arun Brooks, Steven Schoeman, Johan P. Lack, Justin Leisewitz, Andrew Ackerman, Hans BMC Genomics Research BACKGROUND: Babesia rossi is a leading cause of morbidity and mortality among the canine population of sub-Saharan Africa, but pathogenesis remains poorly understood. Previous studies of B. rossi infection were derived from clinical cases, in which neither the onset of infection nor the infectious inoculum was known. Here, we performed controlled B. rossi inoculations in canines and evaluated disease progression through clinical tests and whole blood transcriptomic profiling. RESULTS: Two subjects were administered a low inoculum (10(4) parasites) while three received a high (10(8) parasites). Subjects were monitored for 8 consecutive days; anti-parasite treatment with diminazene aceturate was administered on day 4. Blood was drawn prior to inoculation as well as every experimental day for assessment of clinical parameters and transcriptomic profiles. The model recapitulated natural disease manifestations including anemia, acidosis, inflammation and behavioral changes. Rate of disease onset and clinical severity were proportional to the inoculum. To analyze the temporal dynamics of the transcriptomic host response, we sequenced mRNA extracted from whole blood drawn on days 0, 1, 3, 4, 6, and 8. Differential gene expression, hierarchical clustering, and pathway enrichment analyses identified genes and pathways involved in response to hemolysis, metabolic changes, and several arms of the immune response including innate immunity, adaptive immunity, and response to viral infection. CONCLUSIONS: This work comprehensively characterizes the clinical and transcriptomic progression of B. rossi infection in canines, thus establishing a large mammalian model of severe hemoprotozoal disease to facilitate the study of host-parasite biology and in which to test novel anti-disease therapeutics. The knowledge gained from the study of B. rossi in canines will not only improve our understanding of this emerging infectious disease threat in domestic dogs, but also provide insight into the pathobiology of human diseases caused by Babesia and Plasmodium species. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-021-07889-4. BioMed Central 2021-08-16 /pmc/articles/PMC8369750/ /pubmed/34399690 http://dx.doi.org/10.1186/s12864-021-07889-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Smith, Rachel L.
Goddard, Amelia
Boddapati, Arun
Brooks, Steven
Schoeman, Johan P.
Lack, Justin
Leisewitz, Andrew
Ackerman, Hans
Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title_full Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title_fullStr Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title_full_unstemmed Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title_short Experimental Babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
title_sort experimental babesia rossi infection induces hemolytic, metabolic, and viral response pathways in the canine host
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369750/
https://www.ncbi.nlm.nih.gov/pubmed/34399690
http://dx.doi.org/10.1186/s12864-021-07889-4
work_keys_str_mv AT smithrachell experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT goddardamelia experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT boddapatiarun experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT brookssteven experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT schoemanjohanp experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT lackjustin experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT leisewitzandrew experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost
AT ackermanhans experimentalbabesiarossiinfectioninduceshemolyticmetabolicandviralresponsepathwaysinthecaninehost